Dual-energy CT Angiography of Chronic Thromboembolic Disease: Can It Help Recognize Links Between the Severity of Pulmonary Arterial Obstruction and Perfusion Defects?
Overview
Authors
Affiliations
Purpose: To evaluate whether dual-energy CT angiography (DE-CTA) could identify links between morphologic and functional abnormalities in chronic pulmonary thromboembolism (CPTE).
Materials And Methods: Seventeen consecutive patients with CPTE without underlying cardio-respiratory disease were investigated with DE-CTA. Two series of images were generated: (a) transverse diagnostic scans (i.e., contiguous 1-mm thick averaged images from both tubes), and (b) perfusion scans (i.e., images of the iodine content within the microcirculation; 4-mm thick MIPs). Two radiologists evaluated by consensus the presence of: (a) pulmonary vascular features of CPTE and abnormally dilated systemic arteries on diagnostic CT scans, and (b) perfusion defects of embolic type on perfusion scans.
Results: Diagnostic examinations showed a total of 166 pulmonary arteries (166/833; 19.9%) with features of CPTE, more frequent at the level of peripheral than central arteries (8.94 vs 0.82; p<0.0001), including severe stenosis with partial (97/166; 58.4%) or complete (20/166; 12.0%) obstruction, webs and bands (37/166; 22.3%), partial filling defects without stenosis (7/166; 4.2%), focal stenosis (4/166; 2.4%) and abrupt vessel narrowing (1/166; 0.6%). Perfusion examinations showed 39 perfusion defects in 8 patients (median number: 4.9; range: 1-11). The most severe pulmonary arterial features of CPTE were seen with a significantly higher frequency in segments with perfusion defects than in segments with normal perfusion (p<0.0001). Enlarged systemic arteries were observed with a significantly higher frequency ipsilateral to lungs with perfusion defects (9/12; 75%) compared with lungs without perfusion defects (5/22; 22.7%) (p=0.004).
Conclusion: Dual-energy CTA demonstrates links between the severity of pulmonary arterial obstruction and perfusion impairment, influenced by the degree of development of the systemic collateral supply.
Remy-Jardin M, Guiffault L, Oufriche I, Duhamel A, Flohr T, Schmidt B Eur Radiol. 2024; 34(12):7831-7844.
PMID: 38967660 DOI: 10.1007/s00330-024-10888-0.
Ozawa Y, Ohno Y, Nagata H, Tamokami K, Nishikimi K, Oshima Y Diagnostics (Basel). 2023; 13(13).
PMID: 37443688 PMC: 10340383. DOI: 10.3390/diagnostics13132295.
Si-Mohamed S, Zumbihl L, Turquier S, Boccalini S, Mornex J, Douek P Diagnostics (Basel). 2023; 13(4).
PMID: 36832256 PMC: 9955200. DOI: 10.3390/diagnostics13040769.
Abbasi B, Darvish A, Akhavan R, Pezeshki Rad M, Farrokh D, Emadzadeh M Iran J Med Sci. 2022; 47(4):360-366.
PMID: 35919084 PMC: 9339105. DOI: 10.30476/IJMS.2021.88058.1926.
Abozeed M, Conic S, Bullen J, Rizk A, Bin Saeedan M, Karim W Cardiovasc Diagn Ther. 2022; 12(3):305-313.
PMID: 35800352 PMC: 9253168. DOI: 10.21037/cdt-21-686.